Hologic, Inc. (0J5Q.L)
USD 58.38
(1.81%)
USD 58.38
(1.81%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 679.8 Million USD | 10.07% |
| 2023 | 617.6 Million USD | -0.98% |
| 2022 | 623.7 Million USD | 24.44% |
| 2021 | 501.2 Million USD | 26.85% |
| 2020 | 395.1 Million USD | -11.19% |
| 2019 | 444.9 Million USD | 15.83% |
| 2018 | 384.1 Million USD | 15.83% |
| 2017 | 331.6 Million USD | 20.71% |
| 2016 | 274.7 Million USD | -2.97% |
| 2015 | 283.1 Million USD | -14.37% |
| 2014 | 330.6 Million USD | 14.24% |
| 2013 | 289.4 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 665.5 Million USD | 2.51% |
| 2024 Q2 | 649.2 Million USD | 2.46% |
| 2024 Q1 | 633.6 Million USD | 2.59% |
| 2024 Q4 | 679.8 Million USD | 2.15% |
| 2023 Q3 | 680.1 Million USD | -1.09% |
| 2023 Q4 | 617.6 Million USD | -9.19% |
| 2023 FY | 617.6 Million USD | -0.98% |
| 2023 Q1 | 677.7 Million USD | 8.66% |
| 2023 Q2 | 687.6 Million USD | 1.46% |
| 2022 Q1 | 518.29 Million USD | 3.41% |
| 2022 FY | 623.7 Million USD | 24.44% |
| 2022 Q4 | 623.7 Million USD | 7.31% |
| 2022 Q3 | 581.2 Million USD | 10.47% |
| 2022 Q2 | 526.1 Million USD | 1.5% |
| 2021 Q1 | 420.2 Million USD | 6.35% |
| 2021 Q3 | 502.9 Million USD | 10.24% |
| 2021 Q4 | 501.2 Million USD | -0.34% |
| 2021 FY | 501.2 Million USD | 26.85% |
| 2021 Q2 | 456.2 Million USD | 8.57% |
| 2020 Q3 | 413.6 Million USD | 3.07% |
| 2020 Q4 | 395.1 Million USD | -4.47% |
| 2020 FY | 395.1 Million USD | -11.19% |
| 2020 Q1 | 380.8 Million USD | -14.41% |
| 2020 Q2 | 401.3 Million USD | 5.38% |
| 2019 Q3 | 467.9 Million USD | 5.53% |
| 2019 FY | 444.9 Million USD | 15.83% |
| 2019 Q4 | 444.9 Million USD | -4.92% |
| 2019 Q2 | 443.4 Million USD | 5.92% |
| 2019 Q1 | 418.6 Million USD | 8.98% |
| 2018 FY | 384.1 Million USD | 15.83% |
| 2018 Q3 | 370.5 Million USD | 2.38% |
| 2018 Q4 | 384.1 Million USD | 3.67% |
| 2018 Q1 | 358.2 Million USD | 8.02% |
| 2018 Q2 | 361.9 Million USD | 1.03% |
| 2017 FY | 331.6 Million USD | 20.71% |
| 2017 Q1 | 258.3 Million USD | -5.97% |
| 2017 Q2 | 384 Million USD | 48.66% |
| 2017 Q3 | 357 Million USD | -7.03% |
| 2017 Q4 | 331.6 Million USD | -7.11% |
| 2016 FY | 274.7 Million USD | -2.97% |
| 2016 Q4 | 274.7 Million USD | -2.07% |
| 2016 Q3 | 280.5 Million USD | -1.61% |
| 2016 Q2 | 285.1 Million USD | -0.45% |
| 2016 Q1 | 286.4 Million USD | 1.17% |
| 2015 FY | 283.1 Million USD | -14.37% |
| 2015 Q4 | 283.1 Million USD | -4.03% |
| 2015 Q3 | 295 Million USD | -1.07% |
| 2015 Q2 | 298.2 Million USD | -3.9% |
| 2015 Q1 | 310.3 Million USD | -6.14% |
| 2014 FY | 330.6 Million USD | 14.24% |
| 2014 Q4 | 330.6 Million USD | 0.24% |
| 2014 Q3 | 329.8 Million USD | 6.05% |
| 2014 Q2 | 310.98 Million USD | 3.07% |
| 2014 Q1 | 301.7 Million USD | 4.25% |
| 2013 Q4 | 289.4 Million USD | -5.43% |
| 2013 Q3 | 306.01 Million USD | -4.37% |
| 2013 Q2 | 319.99 Million USD | -7.33% |
| 2013 Q1 | 345.3 Million USD | 0.0% |
| 2013 FY | 289.4 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -391.455% |
| Align Technology, Inc. | 296.9 Million USD | -128.964% |
| Elevance Health Inc. | -46.33 Billion USD | 101.467% |
| AxoGen, Inc. | 23.02 Million USD | -2853.084% |
| Boston Scientific Corporation | 2.48 Billion USD | 72.633% |
| CVS Health Corporation | 18.02 Billion USD | 96.229% |
| Cardinal Health, Inc. | 14.95 Billion USD | 95.455% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -375.036% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 66.363% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -78.762% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -43.236% |
| Masimo Corporation | 545 Million USD | -24.734% |
| McKesson Corporation | 21.13 Billion USD | 96.784% |
| Patterson Companies, Inc. | 782.89 Million USD | 13.169% |
| Quest Diagnostics Incorporated | 190 Million USD | -257.789% |
| ResMed Inc. | 822.25 Million USD | 17.324% |
| Henry Schein, Inc. | 1.81 Billion USD | 62.545% |
| Teladoc Health, Inc. | 29.51 Million USD | -2203.392% |
| Universal Health Services, Inc. | 216.98 Million USD | -213.289% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 75.928% |
| Becton, Dickinson and Company | 3.27 Billion USD | 79.23% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 44.306% |
| Danaher Corporation | 2.59 Billion USD | 73.793% |
| Stryker Corporation | 4.84 Billion USD | 85.963% |
| Medtronic plc | 5.21 Billion USD | 86.97% |